Strand, Vibeke
Bender, Shaun
McCabe, Dorothy
Clinical trials referenced in this document:
Documents that mention this clinical trial
Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid arthritis: results from the phase III randomised VOLTAIRE-RA equivalence study (Results)
https://doi.org/10.1136/annrheumdis-2017-212245
Effects of Adalimumab-adbm Versus Adalimumab Reference Product on Patient-Reported Outcomes in Rheumatoid Arthritis: Results from VOLTAIRE-RA
https://doi.org/10.1007/s40744-024-00687-w
Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity
https://doi.org/10.1007/s40744-020-00259-8
FRI0189 Similar efficacy and safety of biosimilar candidate BI 695501 and adalimumab originator reference product in patients with moderate to severe active rheumatoid arthritis: 24 week results from a phase III clinical study (voltaire®-ra)
https://doi.org/10.1136/annrheumdis-2017-eular.3405
Funding for this research was provided by:
Boehringer Ingelheim
Article History
Received: 11 December 2023
Accepted: 30 May 2024
First Online: 9 August 2024
Declarations
:
: Vibeke Strand is a consultant for AbbVie, Alpine Immune Sciences, Alumis, Amgen, Aria, AstraZeneca, Atom Bioscience, Bayer, Bioventus, Blackrock, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol Myers Squibb, Celltrion, Chemocentryx, Eli Lilly and Company, Equillium, Ermium, Fortress Biotech, Genentech/Roche, Gilead Sciences, GlaxoSmithKline, Horizon, Inmedix, Janssen, Kiniksa, Merck, MiMedx, Novartis, Pfizer, Rapt, Regeneron, R-Pharma, Samsung, Sandoz, Sanofi, Scipher, Setpoint, Sorrento, Spherix, and Tonix. Shaun Bender is a former employee of Boehringer Ingelheim Pharmaceuticals, Inc. and an employee of Alnylam Pharmaceuticals, Cambridge, MA, USA. Dorothy McCabe is a former employee of Boehringer Ingelheim Pharmaceuticals, Inc.
: The protocol for VOLTAIRE-RA was approved by the applicable independent ethics committee or institutional review board at each participating site, and the trial was performed in accordance with Good Clinical Practice and the Declaration of Helsinki. Written informed consent was obtained from all patients before their participation.